During the past decade, Palmetto Health South Carolina Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palmetto Health South Carolina Cancer Center" #1 sponsor was "Children's Oncology Group" with 34 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palmetto Health South Carolina Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Children's Oncology Group" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Palmetto Health South Carolina Cancer Center" are "Sarcoma" (10 trials), "Leukemia" (8 trials), "Neuroblastoma" (7 trials), "Brain Tumor" (3 trials) and "Brain and Central Nervous System Tumors" (3 trials). Many other conditions were trialed in "Palmetto Health South Carolina Cancer Center" in a lesser frequency.

Most popular intervention types in "Palmetto Health South Carolina Cancer Center" are "Drug" (37 trials), "Biological" (18 trials), "Radiation" (16 trials), "Procedure" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (16 trials), "filgrastim" (15 trials), "etoposide" (14 trials), "radiation therapy" (14 trials) and "doxorubicin hydrochloride" (11 trials). Other intervention names were less common.

The vast majority of trials in "Palmetto Health South Carolina Cancer Center" are 40 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Palmetto Health South Carolina Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Palmetto Health South Carolina Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Palmetto Health South Carolina Cancer Center, 5 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".